18.8.05

if you want to know how to fix a lot of the mess in iraq, one need look no further than canada.

how is that?

less 'foreign oil dependence' can be achieved. henry ford understood this. so did charles kettering.

17.8.05

Story from BBC NEWS:

Controversy over US drug adverts
By Matthew Davis
BBC News, Washington

The US pharmaceutical industry has just brought in a new code to tackle concerns that "direct-to-consumer advertising" is misleading the public on the benefits and risks of prescription drugs.

But for some, the latest attempt to regulate this controversial meeting point of commerce and medicine does not go far enough.

Turn on the television in the US and it will not be long before you are being sold the latest solution to anything from managing your menopause to beating your erectile dysfunction problem.

Drug manufacturers say such adverts - often comprising emotional testimony from sufferers - allow people to take control of their own health.

But as greater access to information continues to influence the relationship between doctor and patient, the quality of that information has become more important than ever.

Consumer groups and politicians have been getting increasingly concerned about the over-selling of the benefits, and under-selling of the risks, of prescription drugs.

Criticism grew into a chorus last year after safety scandals hit several heavily-advertised medications, including the pain-reliever Vioxx.

New code

In a sign of the continuing controversy over consumer ads, the industry's average monthly spending on them fell this month for the first time in six years, from $358m to $351m.


We must ask ourselves: 'Are these ads, which we know are costing billions, properly educating patients or just peddling expensive products?'
Senator Bill Frist (R)

At around the same time, the Pharmaceutical Research and Manufacturers of America unveiled a set of voluntary codes designed to restore confidence.

The PhRMA says companies should pitch adult products at adult audiences and urges firms to fully educate doctors about new medicines before launching their ad campaigns.

Adverts should be clearer about the conditions the drug can treat - and the major risks involved, the PhRMA's code says.

PhRMA president Billy Tauzin says patients "need accurate and timely information and should be encouraged to discuss diseases and treatment options with their physicians".

But opponents say the move is just a sop, designed to stave off the prospect of Congress taking sterner, legislative action.

Rob Schneider, director of Consumers Union's prescription drug reform effort, www.PrescriptionForChange.org, said: "What we clearly need is more authority and resources to ensure that all marketing, not just the amount spent on direct-to-consumer advertising, is honest and accurate."

Patient demands

The leading Republican lawmaker in the Senate, Bill Frist, launched a recent broadside, calling for a two-year moratorium on advertising after a drug's launch, so any latent ill-effects can be picked up on.

He argues that "mindless drug advertising" is driving up the costs of medicines.

"Turn on your TV, and within 15 minutes you'll be bombarded by dreamy ads that suggestively over-promise and, even more likely, will make you and your children experts on erectile dysfunction," Mr Frist told the Commonwealth Club of California in San Francisco.

"We must ask ourselves: 'Are these ads, which we know are costing billions, properly educating patients or just peddling expensive products?'"

Drug advertising, he added, "leads patients to demand from their doctor drugs that they may not need or, even worse, that might expose them to risks they didn't know about".

Drug advertising has the potential to educate patients about the latest therapies.

Indeed, a recent study by the US Food and Drug Administration found ads increased awareness of new treatments, and that most doctors felt they helped discussions about health matters with their patients.

But the study also found that adverts unnecessarily increased patients' anxieties about their health, and that doctors felt under pressure to prescribe specific medicines.

Changing relationship

Doctors say that consumer ads increase demands from patients for specific medication - which may or may not be suitable for them to take.

In June, the American Medical Association voted to further study the issue because of "concerns about the effects of these ads on the patient-doctor relationship and health care costs".

The AMA supports patients' increased access to drug information, but "questions whether DTC drug advertising, designed to sell a product, provides the objective and accurate information patients need".

Dr Edward Langston, a family medicine practitioner and an AMA trustee, told the BBC: "There is a lot of information out there, but the difficulty is that patients don't know what is good and what is bad.

"Television advertising tends to give a very unbalanced view, an unrealistic expectation of what a drug can do, and how it can be used.

"The new guidelines are a great first step, but we will have to see how much discipline companies have."

---
hey morons, most of you passed the law in 1996 that allowed this propaganda of pills that do little to keep people well. or don't you remember? big pharma has plenty of pills to make you forget.

"ask your doctor if 'trademarked name' is right for you", that is utter crap. using crafted advertspeak to get around the 'legal claims' nonsense should be hint one. thereby calling anything ingestible not manufactured by big pharma as a 'supplement', and proceeding to pay off the legislature and the courts to ban as many as possible, hint two.

with all the kneejerk press methamphetamine has received, there is little mentioned about the painkiller problem this country faces. not that i'm for meth addicts, let's just keep it in perspective.

15.8.05



Millions to fight marijuana, with little to show for it


Ronald Fraser
Fraser writes on public policy issues for the DKT Liberty Project, a Washington-based civil liberties organization.

Virginians spend about $99 million each year to enforce state and local marijuana laws. What are taxpayers getting for their money? Not much, according to a recent study.

Jon B. Gettman, a senior fellow at George Mason University's School of Public Policy, prepared the study, titled "Crimes of Indiscretion: Marijuana Arrests in the United States," for the National Organization for the Reform of Marijuana Laws.

"Marijuana arrests," says Gettman, "are instruments of a supply-reduction policy. But, he adds, "The doubling of marijuana arrests in the 1990s has produced the opposite of the intended effect in every major indicator. An increase in arrests should produce a reduction in use and the availability of marijuana. However, during the 1990s both use and availability of marijuana increased."

Marijuana possession arrests in the U.S. totaled 260,000 in 1990. By 2003, that figure topped 662,000. Even failed public policies, however, can cost a bundle.

Virginians are, in effect, paying for Washington's marijuana prohibition policies. "The use of criminal law to control the availability and use of marijuana," says Gettman, "is a federal policy that is dependent on local law enforcement for its implementation." And state and local costs quickly add up.

A Boston University economics professor, Jeffrey A. Miron, estimates that state and local officials spend about $5 billion a year enforcing marijuana laws. Virginia's share is: $31 million for police services; $56 million for judicial services; $12 million for correctional services.

The thousands of persons arrested on marijuana possession charges in Virginia each year -- especially teenagers -- pay extra. "Marijuana arrests," Gettman stresses, "make criminals out of otherwise law-abiding citizens. Indeed, the primary consequence of marijuana arrests is the introduction of hundreds of thousands of young people into the criminal justice system."

Once a teenager has a criminal record, other penalties often follow. In Virginia, employers can ask job applicants about arrests, even arrests not leading to a conviction, and a criminal record may bar a person from public housing.

Taking a close look at marijuana arrest patterns, Gettman notes that young people are disproportionally targeted. "The brunt of marijuana law enforcement," he says, "falls on both adolescents and the youngest adults -- on teenagers." Nationally, almost 17 percent of all persons arrested for possession of marijuana were between 15 and 17 years old. Another 26 percent were age 18-20.

And what do Virginians get for these financial and personal costs? In 2002, there were 12,798 marijuana possession arrests in Virginia, but the number of users keeps going up. While 4 percent of Virginia's population was estimated to be monthly users in 1999, in 2002 the estimate stood at 6.4 percent. Nationally, monthly users went from 4.9 percent in 1999 to 6.2 percent in 2002.

The basic problem, says Gettman, is that the "Overall supply of marijuana in the U.S. is far too diversified to be controlled by law enforcement."

If the current marijuana policies are both costly and ineffective, what is the next best strategy? Because marijuana is so widely used, Gettman recommends treating marijuana like a pharmaceutical product subject to Federal Drug Administration testing and regulatory requirements.

By shifting to a policy that treats and taxes marijuana like tobacco and alcohol, Virginians could gain the following benefits: a decrease in illegal activities surrounding drug sales; government control of marijuana quality; better control of underage access to marijuana; and removal of the profit motive that attracts sellers, including a substantial number of teenage sellers who, most frequently, supply other teenagers.

On top of that, Miron estimates a marijuana sales tax would replace the $99 million a year Virginia taxpayers are now spending to enforce unenforceable laws, with a new revenue pipeline bringing in $20 million a year.

---

oh dear, a factual article. quick, get the ONDCP to go and spread another 'captain obvious misinformation' - the anti drug ad.

i don't like the proposal to let the FDA near medical cannabis. as if those human beings have not already been bought off by big pharma.

if this isn't pharma induced government pork, please tell me what it is.

12.8.05



cindy sheehan - media whore

there are plenty of other grieving mothers of fallen soldiers in this war and others who aren't making a spectacle of themselves as you are. and unlike you, they don't need several camera crews to broadcast their pain and anger to the world. you have thrown yourself out into the public eye, forgoing your right to privacy.

your son died so you have the freedom to go to crawford and make an ass of yourself.

this is not an endorsement of the shrub administration or their wmd cover story. i just can't stand the media circus that passes for infotainment these days. this is not a real noteworthy story.

neither was this one.



beth holloway (right) - white trash media whore.
natalee holloway (left) - she's dead. deal with it greta, nancy, bill et al.

8.8.05

an example of why negotiating with a fundamentalist is futile, despite what peace loving people think:

peace loving person: what is it you want?

fundamentalist: you to see things my way. it is the only way.

peace loving person: there can be more than one way, if i respect your beliefs.

fundamentalist: you cannot respect my beliefs without seeing it my way.

peace loving person: sure i can, that is what rights and freedoms are all about.

fundamentalist: no, you cannot. there are no rights and freedoms when you do not see it my way.

peace loving person: how is that?

fundamentalist: i am not free to see things your way, because there is only one way. do you not see?

peace loving person: see what?

fundamentalist: my way.

peace loving person: i don't see it your way, but i respect your beliefs.

fundamentalist: then you must die, infidel.

5.8.05


Brad Badelt
Vancouver Sun

2.8.05

the crescent, the cross, the star. 3 symbols, 1 holiest of places. how can this be?

what we have here is a sharing issue.